Diagnostics News and Research

RSS

APPG-GTB members express concern on the growing threat of multi-drug resistant TB

In a Lancet Comment discussing the WHO Global Tuberculosis report 2013 published today [Wednesday 23 October], members of the UK All-Party Parliamentary Group on Global Tuberculosis and lead author Professor Ali Zumla from University College London sound an alarm as the growing threat of multi-drug resistant TB to regional and global health security becomes more apparent.

23 Oct 2013

Vitamin D Total assay for use on Access 2 and UniCel DxI immunoassay systems receives CE Mark

Beckman Coulter, Inc. announces the CE Mark approval of Access 25 (OH) Vitamin D Total assay for use on the Access 2 and UniCel DxI series of immunoassay systems. Offering enhanced performance, the new assay is an important addition to the company’s bone metabolism assay menu.

23 Oct 2013

Viewpoints: 'Unforced error' on marketplace website raises questions about administration's handling of health issues; Obama's 'desperate sales pitch;' GOP's faux concerns for exchanges

Anyone who supports the plan to cover Americans who couldn't get health insurance has to hope the administration quickly gets it right. But you can't help but wonder: Where was all this frantic effort in the three-and-a-half years from the time Obama signed the health law to the day the exchanges opened on Oct. 1?

From Quest Diagnostics 23 Oct 2013

EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers

EKF, announces publication of a new white paper detailing the successful external evaluation of its Quo-Test and Quo-Lab glycated hemoglobin analyzers.

From EKF Diagnostics 23 Oct 2013

Scientists from University of Salzburg, Sandoz Pharmaceuticals and Thermo Fisher Scientific collaborate to advance protein-based pharmaceutical development

The Christian Doppler Laboratory for Biosimilar Characterization is now open at the Paris-Lodron University of Salzburg, and scientists there have commenced developing new methods for characterizing proteins to be used in biopharmaceuticals.

23 Oct 2013

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

A new diagnostic platform to detect BRAF mutations in melanoma and other cancer types is faster and more accurate compared with the standard method currently used in clinics, and this could help accelerate diagnosis and treatment, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

23 Oct 2013

IBM joins with University Hospital Zurich to test new prototype tool for diagnosing cancer

IBM scientists are collaborating with pathologists at the University Hospital Zurich to test a new prototype tool to accurately diagnose different types of cancer. This work is based on a technology developed by IBM scientists called a microfluidic probe, which slightly resembles the nib of a fountain pen.

23 Oct 2013

Amgen Buys Roche Rights To Neutropenia Drugs

...

22 Oct 2013

Novozymes, Almac Ally To Offer Drug Targeting, Pharmacokinetics Service

...

22 Oct 2013

PDL Biopharma Acquires Diabetes Royalty, Milestone Rights For $240.5M

...

22 Oct 2013

Illumina announces launch of TruGenome Undiagnosed Disease Test

Illumina, Inc. today announced the launch of its TruGenome Undiagnosed Disease Test provided by the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.

From Illumina, Inc. 22 Oct 2013

IDEXX Laboratories' revenues increase 7.2% to $338.3 million in Q3 2013

IDEXX Laboratories, Inc., today reported that revenues for the third quarter of 2013 increased 7.2% to $338.3 million, from $315.5 million for the third quarter of 2012.

22 Oct 2013

Study opens doors to novel treatments for aggressive brain cancer

Ludwig researchers have elucidated a key mechanism by which cancer cells change how they metabolize glucose to generate the energy and raw materials required to sustain runaway growth.

22 Oct 2013

U.K. Organizations Partner With Illumina To Sequence 10,000 Whole Genomes

...

From Illumina, Inc. 21 Oct 2013

Medmira Wins Additional $1.9M Army Contract

...

21 Oct 2013

Astrazeneca, Evotec Launch Kidney Disease Collaboration

...

21 Oct 2013

New collaborative project aims to discover genes underlying rare genetic diseases

...

21 Oct 2013

RNA-based gene expression test potentially determine presence or absence of BRAF V600E mutation

Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced preliminary study results suggesting the potential for an RNA-based gene expression test to accurately detect the BRAF V600E gene mutation in thyroid nodule fine needle aspiration (FNA) samples.

19 Oct 2013

Thomson Reuters adds Cortellis Clinical Trials Intelligence for drug discovery and development

The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced the addition of Clinical Trials Intelligence to the Thomson Reuters CortellisTM suite, the industry's most comprehensive information solution for drug discovery and development.

19 Oct 2013

Oral nutritional supplements linked with decreased probability of 30-day hospital readmission

In the U.S., one in five Medicare patients is readmitted to a hospital each year at an estimated cost of $17.5 billion annually.i To reduce this impact, the Affordable Care Act (ACA) has introduced hospital penalties based on readmissions conditions that commonly affect patients aged 65 and older - including acute myocardial infarction, congestive heart failure and pneumonia.

19 Oct 2013

Diagnostics News and Research

APPG-GTB members express concern on the growing threat of multi-drug resistant TB

Vitamin D Total assay for use on Access 2 and UniCel DxI immunoassay systems receives CE Mark

Viewpoints: 'Unforced error' on marketplace website raises questions about administration's handling of health issues; Obama's 'desperate sales pitch;' GOP's faux concerns for exchanges

EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers

Scientists from University of Salzburg, Sandoz Pharmaceuticals and Thermo Fisher Scientific collaborate to advance protein-based pharmaceutical development

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

IBM joins with University Hospital Zurich to test new prototype tool for diagnosing cancer

Amgen Buys Roche Rights To Neutropenia Drugs

Novozymes, Almac Ally To Offer Drug Targeting, Pharmacokinetics Service

PDL Biopharma Acquires Diabetes Royalty, Milestone Rights For $240.5M

Illumina announces launch of TruGenome Undiagnosed Disease Test

IDEXX Laboratories' revenues increase 7.2% to $338.3 million in Q3 2013

Study opens doors to novel treatments for aggressive brain cancer

U.K. Organizations Partner With Illumina To Sequence 10,000 Whole Genomes

Medmira Wins Additional $1.9M Army Contract

Astrazeneca, Evotec Launch Kidney Disease Collaboration

New collaborative project aims to discover genes underlying rare genetic diseases

RNA-based gene expression test potentially determine presence or absence of BRAF V600E mutation

Thomson Reuters adds Cortellis Clinical Trials Intelligence for drug discovery and development

Oral nutritional supplements linked with decreased probability of 30-day hospital readmission

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News